Directing the migration of serum-free, ex vivo-expanded Vγ9Vδ2 T cells

Directing the migration of serum-free, ex vivo-expanded Vγ9Vδ2 T cells

Vγ9Vδ2 T cells represent a promising cancer therapy platform because the implementation of allogenic, off-the-shelf product candidates is possible. However, intravenous administration of human Vγ9Vδ2 T cells manufactured under good manufacturing practice (GMP)-compliant, serum-free conditions are no...

Полное описание

Библиографические подробности
Главные авторы: Kiran K. Parwani, Gianna M. Branella, Rebecca E. Burnham, Andre J. Burnham, Austre Y. Schiaffino Bustamante, Elisabetta Manuela Foppiani, Kristopher A. Knight, Brian G. Petrich, Edwin M. Horwitz, Christopher B. Doering, H. Trent Spencer
Формат: Статья
Язык:English
Опубликовано: Frontiers Media S.A. 2024-02-01
Серии:Frontiers in Immunology
Предметы:
gamma delta T cells
gamma delta T cell migration
bone marrow
blood–bone marrow barrier
cancer immunotherapy
Online-ссылка:https://www.frontiersin.org/articles/10.3389/fimmu.2024.1331322/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2024.1331322/full

Схожие документы